Close

Nasal

Nasal antiviral blocks SARS-CoV-2 infection in mice

SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed to produce antibodies to fight off the Omicron variant of SARS-CoV-2. And several combinations of […]

Read More

Un nuevo candidato a vacuna nasal COVID-19 resulta eficaz para prevenir la transmisión

La vacunación de las mucosas puede estimular la inmunidad tanto sistémica como de las mucosas y tiene la ventaja de ser un procedimiento no invasivo Las vacunas contra la COVID-19 que actualmente se están inoculando en todo el mundo no son esterilizantes, es decir, han demostrado su eficacia y seguridad en la prevención […]

Read More

New Guidelines Advise Expanded Use of High-Flow Nasal Oxygen for Patients With ARDS

Hospitalized patients with acute respiratory failure can benefit from high-flow nasal oxygen in certain settings, according to a new clinical guideline from the American College of Physicians. High-flow nasal oxygen (HFNO) has demonstrated advantages including improved oxygenation and ventilation, wrote Arianne K. Baldomero, MD, of Minneapolis Veterans Affairs Health Care […]

Read More

COVID-19: Monoclonal Antibody / Anxiety & Depression / Helmet Ventilation vs. High-Flow Nasal Oxygen / Bamlanivimab & Variants

Monoclonal antibody treatment: GlaxoSmithKline and Vir Biotechnology are seeking emergency use authorization for their investigational monoclonal antibody treatment for early COVID-19. In an interim analysis of an efficacy trial of nearly 600 adults with COVID-19 who were at high risk for hospitalization, VIR-7831 was associated with an 85% lower risk […]

Read More

Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure

Key Points Question  Among patients admitted to the intensive care unit with COVID-19–induced moderate to severe hypoxemic respiratory failure, does early continuous treatment with helmet noninvasive ventilation increase the number of days free of respiratory support at 28 days as compared with high-flow nasal oxygen? Findings  In this randomized trial […]

Read More
Translate »